Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia

Journal of Pediatrics

Volumn 132, Issue 4, 1998, Pages 709-713

  Hamosh, A ^a   Maher, J F ^a   Bellus, G A ^a   Rasmussen, S A ^a   Johnston, M V ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; DEXTROMETHORPHAN; GLYCINE; GLYCINE CLEAVAGE SYSTEM; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AROUSAL; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFICACY; FEMALE; HUMAN; HYPERGLYCINEMIA; KETOGENESIS; MALE; MENTAL DEFICIENCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

EID: 0031949102     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70365-8     Document Type: Article

References (14)

1. A Hamosh MV Johnston D. Valle Nonketotic hyperglycinemia 7th ed CR Scriver AR Beaudet W Sly D Valle The metabolic and molecular bases of inherited disease. 1995 McGraw-Hill: New York 1337 1348
2. G. Kikuchi The glycine cleavage system: composition, reaction mechanism, and physiological significance Mol Cell Biochem 1 1973 169 187
3. K Tada S. Kure Nonketotic hyperglycinemia: molecular lesion, diagnosis, and pathophysiology J Inherit Metab Dis 16 1993 691 703
4. JW McDonald MV. Johnston Physiological and pathophysiological roles of excitatory amino acids during central nervous system development Brain Res Rev 15 1990 41 70
5. JW Ferkany SA Borosky DB Clissold MJ. Pontecorvo Dextromethorphan inhibits NMDA-induced convulsions Eur J Pharm 151 1988 151 154
6. CG Wasterlain RA Wallis LM Adams K. Panizzon Felbamate is a potent neuroprotective agent Epilepsia 34 1993 92A
7. A Hamosh JW McDonald D Valle CA Francomano E Niedermeyer MV. Johnston Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant J Pediatr 121 1992 131 135
8. JR Toone DA Applegarth HL. Levy Prenatal diagnosis of non-ketotic hyperglycinemia J Inherit Metab Dis 15 1992 713 719
9. J Christodoulou S Kure K Hayasaka JTR. Clarke Atypical nonketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts J Pediatr 123 1993 100 102
10. Y Ohya N Ochi N Mizutani C Hayakawa K. Watanabe Nonketotic hyperglycinemia: treatment with NMDA antagonist and consideration of neuropathogenesis Pediatr Neurol 7 1991 65 68
11. B Schmitt B Steinmann R Gitzelmann L Thun-Hohenstein H Mascher G. Dumermuth Nonketotic hyperglcyinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor Neurololgy 43 1993 421 424
12. B Schmitt R Netzer S Fanconi P Baumann E. Boltshauser Drug refractory epilepsy in brain damage: effect of dextromethorphan on EEG in four patients J Neurol Neurosurg Psychiatry 57 1994 333 339
13. R Alemzadeh K Gammeltoft K. Matteson Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia Pediatrics 97 1996 924 926
14. E Zammarchi MA Donati F Ciani E Pasquini I Pela P. Fiorini Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia Neuropediatrics 25 1994 274 276